Luo L - Search Results

1

Optimized strategy among diet, exercise, and pharmacological interventions for nonalcoholic fatty liver disease: A network meta-analysis of randomized controlled trials.

Wang H, Ma Q, Chen Y, Luo L, Ye J, Zhong B. Wang H, et al. Among authors: luo l. Obes Rev. 2024 Jun;25(6):e13727. doi: 10.1111/obr.13727. Epub 2024 Mar 21. Obes Rev. 2024. PMID: 38509775 Review.

2

Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection.

Luo L, Ye J, Shao C, Lin Y, Sun Y, Feng S, Wang W, Zhong B. Luo L, et al. Nutrients. 2022 May 18;14(10):2114. doi: 10.3390/nu14102114. Nutrients. 2022. PMID: 35631255 Free PMC article.

3

Prevalence and Significance of Antinuclear Antibodies in Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Luo L, Ma Q, Lin L, Wang H, Ye J, Zhong B. Luo L, et al. Dis Markers. 2022 Aug 12;2022:8446170. doi: 10.1155/2022/8446170. eCollection 2022. Dis Markers. 2022. PMID: 35990246 Free PMC article. Review.

4

Alterations in Circulating Bile Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis.

Lai J, Luo L, Zhou T, Feng X, Ye J, Zhong B. Lai J, et al. Among authors: luo l. Biomolecules. 2023 Sep 6;13(9):1356. doi: 10.3390/biom13091356. Biomolecules. 2023. PMID: 37759756 Free PMC article. Review.

5

Restoring skeletal muscle mass as an independent determinant of liver fat deposition improvement in MAFLD.

Zhou T, Ye J, Luo L, Wang W, Feng S, Dong Z, Zhuo S, Zhong B. Zhou T, et al. Among authors: luo l. Skelet Muscle. 2023 Dec 19;13(1):23. doi: 10.1186/s13395-023-00333-z. Skelet Muscle. 2023. PMID: 38115119 Free PMC article.

6

Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment.

Luo L, Ye J, Zhuo S, Ma B, Mai W, Cao X, Liang L, Wang W, Feng S, Dong Z, Zhong B. Luo L, et al. Hepatobiliary Surg Nutr. 2024 Aug 1;13(4):632-649. doi: 10.21037/hbsn-23-393. Epub 2024 Apr 11. Hepatobiliary Surg Nutr. 2024. PMID: 39175719 Free PMC article.

7

Applying 1-hour postload plasma glucose diagnostic criteria reveals high Progressive Risks of potential MASLD.

Teng L, Luo L, Sun Y, Wang W, Dong Z, Cao X, Ye J, Zhong B. Teng L, et al. Among authors: luo l. Diabetes Res Clin Pract. 2024 Dec 22:111973. doi: 10.1016/j.diabres.2024.111973. Online ahead of print. Diabetes Res Clin Pract. 2024. PMID: 39719183 Free article.

8

Comparisons of Post-Load Glucose at Different Time Points for Identifying High Risks of MASLD Progression.

Teng L, Luo L, Sun Y, Wang W, Dong Z, Cao X, Ye J, Zhong B. Teng L, et al. Among authors: luo l. Nutrients. 2024 Dec 31;17(1):152. doi: 10.3390/nu17010152. Nutrients. 2024. PMID: 39796589 Free PMC article.

9

The TNF-α rs361525 and IFN-γ rs2430561 polymorphisms are associated with liver cirrhosis risk: a comprehensive meta-analysis.

Zheng M, Li J, Fang W, Luo L, Ding R, Zeng H, Luo H, Lin X, Duan C. Zheng M, et al. Among authors: luo h, luo l. Front Immunol. 2023 Apr 14;14:1129767. doi: 10.3389/fimmu.2023.1129767. eCollection 2023. Front Immunol. 2023. PMID: 37122734 Free PMC article.

10

Thymidine kinase 1 as a diagnostic tumor marker is of moderate value in cancer patients: A meta-analysis.

Xiang Y, Zeng H, Liu X, Zhou H, Luo L, Duan C, Luo X, Yan H. Xiang Y, et al. Among authors: luo x, luo l. Biomed Rep. 2013 Jul;1(4):629-637. doi: 10.3892/br.2013.114. Epub 2013 May 28. Biomed Rep. 2013. PMID: 24648999 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,182 results

Search Page

Filters